Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Abbott synthesizes a novel series of cyclic antifungal agents

Jan. 2, 1998

Raxar --new once-daily fluoroquinolone-- now available in U.S.

Dec. 31, 1997

New antifungals disclosed by Schering-Plough

Dec. 31, 1997

Lilly develops compounds for the common cold; selects development candidate

Dec. 30, 1997

Aronex/Ferrer seek approval of Nyotran in Spain

Dec. 29, 1997

Lidak submits NDA for Lidakol

Dec. 29, 1997

SS Pharm. patents new antifungal agents

Dec. 29, 1997

BLA filed for palivizumab

Dec. 24, 1997

New antibacterial agent discovered by Sankyo

Dec. 24, 1997

RD4-6250: a potential new treatment for HCV

Dec. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.